Latest Research in HER2/EGFR in Cancer Research
116 research papers · 2026 median publication year
Top Research Topics in HER2/EGFR in Cancer Research
- Glioma Diagnosis and Treatment — 28 papers
- HER2/EGFR in Cancer Research — 14 papers
- Lymphoma Diagnosis and Treatment — 8 papers
- Advanced Breast Cancer Therapies — 7 papers
- Head and Neck Cancer Studies — 6 papers
- CNS Lymphoma Diagnosis and Treatment — 6 papers
- Cancer Immunotherapy and Biomarkers — 5 papers
- Neuroblastoma Research and Treatments — 3 papers
- Veterinary Oncology Research — 3 papers
- Cancer Treatment and Pharmacology — 2 papers
Highest-Cited Papers
- Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer
- Precision medicine for pediatric gliomas
- Clinical Outcomes of Sacituzumab Govitecan in Breast Cancer
- Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma
- Neoadjuvant Immune Checkpoint Inhibitor Therapy in Temporal Bone Squamous Cell Carcinoma
- Safety management of anti TROP2 ADCs in patients with breast cancer
- Immunotherapy in Head and Neck Squamous Cell Carcinoma With PD-L1 Combined Positive Score Less Than 1
- Nasopharyngeal carcinoma: epidemiology, risk factors, signaling pathways, clinical features, diagnosis, and management
- E7389-LF as a first-line chemotherapy for patients with metastatic/advanced HER2-negative breast cancer: results from the phase 1 dose-expansion part of study 114
- Anti–B7-H3 ADCs Take Center Stage against SCLC at WCLC
- Dinutuximab beta-based first-line maintenance therapy for newly diagnosed high-risk neuroblastoma following a COG-based pathway: a single-center real-world study in China
- “Updates on diagnostic and prognostic molecular biomarkers of CNS tumors”
- CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas
- Efficacy, safety and circulating tumor cell dynamics in patients treated with Eribulin for HER2-negative advanced breast cancer – results from the phase II DETECT IVb trial
- Multiple HRAS Hot-Spot Somatic Variations in a Patient With Eruptive Disseminated Spitz Nevi
- Dual inhibition of PLK1 and CDK1/2 selectively suppresses the growth of canine squamous cell carcinoma cell lines with truncating TP53 mutations
- A kit formulated under good manufacturing practices (GMP) for preparing [89Zr]Zr-Bn-DFO-Pembrolizumab injection for human administration and associated preclinical imaging, biodistribution, dosimetry and toxicity studies
- Emerging cfDNA technologies in glioblastoma through fragmentomics and sonobiopsy
- Development and validation of a DNA methylation-based classifier for CNS tumors using a large Chinese cohort (n = 1,581)
- Hypoxia Response Is Associated with Reduced HPV Activity and Tumor Microenvironment Remodeling in Cervical Cancer